X

Health & Biotech

The 6 ASX small cap biotechs that have more than doubled in 2020

Six ASX biotech small caps are sitting on gains over 100 per cent in 2020. Despite the global biotech industry…

Wellness & Beauty Solutions breaks hand sanitiser news drought with $3m deal

After a few quiet weeks for hand sanitiser plays, Wellness & Beauty Solutions (ASX:WNB) has broken the silence with news of…

Hydrix rolls out ‘heart attack warning system’ into Asian market, shares bounce off lows

The medtech division of diversified engineering firm Hydrix (ASX:HYD) has implanted its AngelMed Guardian heart-monitoring system in four patients in…

G Medical to delist from ASX despite a May promise to stay

With its stock plumbing all time lows, G Medical (ASX:GMV) is making good on a promise first made in 2018…

How CardieX is disrupting the last legacy health sector

Special Report: Blood pressure monitoring tech is a 100 years old, so CardieX is about to shake things up with…

Dr Boreham’s Crucible: Regeneus is now riding the stem cell rollercoaster upwards

The roller-coaster of the emerging stem cell therapies sector was felt acutely on Wednesday and Friday last week -- both…

StockTalk: How are ASX medtechs responding to skyrocketing healthcare spending?

StockTalk is a Stockhead video series featuring a roundtable of experts discussing a new investment topic each week. In this edition, host…

MGC Pharma secures UK distributor for its medicinal cannabis treatments

Biopharma MGC Pharmaceuticals (ASX:MXC) has signed UK market leading medicinal cannabis provider LYPHE Group as its distribution partner for the country.…

Mesoblast caps off rollercoaster week with key tick of approval from US regulators

Stem cell company Mesoblast (ASX:MSB) got some good news this morning -- a key US regulatory committee reckons its RYONCIL…

Meluka’s honey flying off the shelves in China

Special Report: Meluka Australia has chalked up another major milestone by selling out its entire second shipment of honey to…